Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03492541 · ClinicalTrials.gov registry record · NA
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT03492541 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 134 participants.
The verdict
NCT03492541, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the clinical effectiveness and tolerability of SYSTANE® Complete in adult patients with dry eye disease. Fluorescein-stained tear film break-up time (TFBUT) will be evaluated as the primary objective.
Interventions
- OTHER Propylene glycol-based eye drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2018-07-18 |
| Est. Completion | 2019-05-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03492541
The ClinicalTrials.gov registry entry for NCT03492541 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Propylene glycol-based eye drops is the first listed.
NCT03492541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03492541 about?
NCT03492541 is a clinical study titled "Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease". The purpose of this study is to evaluate the clinical effectiveness and tolerability of SYSTANE® Complete in adult patients with dry eye disease. Fluorescein-stained tear film break-up time (TFBUT) will be evaluated as the primary objective.
What is the current status of trial NCT03492541?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2018-07-18. Estimated completion is 2019-05-14.
What interventions are being tested in trial NCT03492541?
The interventions under investigation include: Propylene glycol-based eye drops (OTHER).
Who is sponsoring clinical trial NCT03492541?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.